Additionally, Wen et al. also found that in AR-positive C4-2 and LNCaP cells, ASC-J9 could suppress significant FASN expression and FASN-mediated prostate cancer progression through the AR-dependent pathway (Wen et al., 2016). The gene discussed is FASN; the disease is prostate carcinoma.